|
Volumn 30, Issue 4, 2002, Pages 525-529
|
Cholesterol and Alzheimer's disease
|
Author keywords
secretase; Amyloid peptide; Statin
|
Indexed keywords
AMYLOID BETA PROTEIN;
AMYLOID BETA PROTEIN ANTIBODY;
AMYLOID PRECURSOR PROTEIN;
ATORVASTATIN;
BETA SECRETASE;
CHOLESTEROL;
CHOLESTEROL ESTER;
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
ENZYME INHIBITOR;
GAMMA SECRETASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
METHYL BETA CYCLODEXTRIN;
MEVINOLIN;
PRAVASTATIN;
PRESENILIN 1;
PROTEIN ANTIBODY;
RAS PROTEIN;
RHO FACTOR;
STATIN;
TACRINE;
UNCLASSIFIED DRUG;
ALZHEIMER DISEASE;
BLOOD BRAIN BARRIER;
BRAIN LEVEL;
CELL LEVEL;
CHOLINERGIC NERVE CELL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIFFUSION;
DISEASE COURSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG PENETRATION;
DRUG SAFETY;
ENZYME INHIBITION;
HUMAN;
LIPID METABOLISM;
MEYNERT BASAL NUCLEUS;
NERVE CELL DEGENERATION;
NONHUMAN;
PATHOGENESIS;
PATHOPHYSIOLOGY;
PEPTIDE SYNTHESIS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN METABOLISM;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
ALZHEIMER DISEASE;
AMYLOID BETA-PROTEIN PRECURSOR;
AMYLOID PRECURSOR PROTEIN SECRETASES;
ASPARTIC ENDOPEPTIDASES;
CHOLESTEROL;
ENDOPEPTIDASES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
ANIMALIA;
|
EID: 0036670693
PISSN: 03005127
EISSN: None
Source Type: Journal
DOI: 10.1042/BST0300525 Document Type: Conference Paper |
Times cited : (47)
|
References (28)
|